ChromaDex Corp. financial data

Symbol
CDXC on Nasdaq
Industry
Medicinal Chemicals & Botanical Products
Location
10900 Wilshire Blvd, Suite 600, Los Angeles, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
CODY RESOURCES, INC. (to 6/24/2008)
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 264 % +5.91%
Quick Ratio 64.9 % -5.19%
Debt-to-equity 79.3 % -14.7%
Return On Equity 4.85 %
Return On Assets 2.7 %
Operating Margin 0.49 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 76.4M shares +1.68%
Common Stock, Shares, Outstanding 76M shares +1.49%
Entity Public Float 81.1M USD +2.4%
Common Stock, Value, Issued 76K USD +1.33%
Weighted Average Number of Shares Outstanding, Basic 76M shares +1.23%
Weighted Average Number of Shares Outstanding, Diluted 77.8M shares +3.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 91.7M USD +9.95%
Cost of Revenue 35.3M USD +5.46%
Research and Development Expense 5.86M USD +15.4%
Selling and Marketing Expense 27.3M USD +4.47%
General and Administrative Expense 22.7M USD -11%
Operating Income (Loss) 447K USD
Net Income (Loss) Attributable to Parent 1.49M USD
Earnings Per Share, Basic 0.01 USD/shares
Earnings Per Share, Diluted 0.01 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32.2M USD +21.1%
Accounts Receivable, after Allowance for Credit Loss, Current 7.1M USD
Inventory, Net 10.5M USD -16.5%
Assets, Current 52.1M USD +10.5%
Operating Lease, Right-of-Use Asset 1.9M USD -36.8%
Intangible Assets, Net (Excluding Goodwill) 397K USD -28.1%
Other Assets, Noncurrent 374K USD -17.6%
Assets 56.5M USD +5.68%
Accounts Payable, Current 6.9M USD -25%
Accrued Liabilities, Current 9.59M USD +4.34%
Liabilities, Current 17.7M USD -8.97%
Contract with Customer, Liability, Noncurrent 2.58M USD -32.2%
Operating Lease, Liability, Noncurrent 1.87M USD -35.7%
Liabilities 22.2M USD -15.4%
Retained Earnings (Accumulated Deficit) -189M USD +0.78%
Stockholders' Equity Attributable to Parent 34.4M USD +25.9%
Liabilities and Equity 56.5M USD +5.68%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 295K USD -89.4%
Net Cash Provided by (Used in) Financing Activities -14K USD
Net Cash Provided by (Used in) Investing Activities -41K USD +54.9%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 76M shares +1.49%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 240K USD -91.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.4M USD +21%
Deferred Tax Assets, Valuation Allowance 46.4M USD +0.3%
Deferred Tax Assets, Gross 46.7M USD +0.51%
Operating Lease, Liability 2.88M USD -23.5%
Depreciation 178K USD -21.9%
Lessee, Operating Lease, Liability, to be Paid 3.13M USD -26.2%
Operating Lease, Liability, Current 1.01M USD +18%
Lessee, Operating Lease, Liability, to be Paid, Year Two 901K USD -20.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.14M USD +3.09%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +17.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 252K USD -47.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 491K USD -45.5%
Deferred Tax Assets, Operating Loss Carryforwards 36.7M USD -1.54%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 358K USD -27.1%
Operating Lease, Payments 91K USD -49.4%
Additional Paid in Capital 223M USD +2.56%
Amortization of Intangible Assets 38K USD -7.32%
Deferred Tax Assets, Net of Valuation Allowance 358K USD +39.3%
Interest Expense 32K USD -48.4%